Researchers uncover how deadly MRSA pneumonia inhibits body's antimicrobial activity

NewsGuard 100/100 Score

In a recent study published in the American Journal of Physiology-Lung Cellular and Molecular Physiology, a group of researchers examined how heparan sulfate (HS)shedding impacts cathelicidin efficacy in Methicillin-Resistant Staphylococcus aureus (MRSA) pneumonia.

Study: Bacterial pneumonia-induced shedding of epithelial heparan sulfate inhibits the bactericidal activity of cathelicidin in a murine model. Image Credit: Tatiana Shepeleva/Shutterstock.com
Study: Bacterial pneumonia-induced shedding of epithelial heparan sulfate inhibits the bactericidal activity of cathelicidin in a murine model. Image Credit: Tatiana Shepeleva/Shutterstock.com

Background 

Pneumonia, particularly caused by MRSA, is a leading cause of infectious mortality. The mechanisms leading to Staphylococcal pneumonia are not fully understood. This study explores the interactions between MRSA, the pulmonary epithelial glycocalyx, and antimicrobial peptides (AMPs) in pneumonia.

The focus is on the HS enriched glycocalyx, a sulfated layer lining the alveoli known to bind cationic proteins. We examine the shedding of HS into the airspace following lung injury and its potential impact on lung function and interactions with AMPs. Specifically, we investigate how shed HS oligosaccharides, especially during bacterial pneumonia, interact with AMPs like cathelicidins, impacting the host immune response and pathogen dynamics.

Further research is needed to fully understand the mechanisms by which HS shedding impacts AMP function, offering potential for novel therapeutic strategies in pneumonia treatment.

About the study 

In this study, following the University of Colorado's Institutional Animal Care and Use Committee (IACUC) and Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines, male C57BL6 mice underwent intratracheal MRSA instillation, followed by bronchoalveolar lavage (BAL) for fluid analysis. Researchers used mass spectrometry to measure HS in BAL fluid, blind to treatment groups for objective results.

Additionally, the team innovatively collected airspace fluid from pneumonia patients using heat and moisture exchanger (HME) filters at Vanderbilt University Medical Center under an approved Institutional Review Board (IRB) protocol. This aimed to detect lung changes due to respiratory failure.

The study employed surface plasmon resonance (SPR) to examine the binding kinetics between AMP  and HS, providing real-time, label-free interaction insights. Concurrently, bacterial growth curves were studied under various conditions to assess the effect of different heparin types on MRSA strains.

Detailed processes of bacterial ribonucleic acid (RNA) isolation and sequencing were conducted, involving MRSA culture in heparin or saline, followed by RNA extraction and sequencing. These steps were crucial in exploring transcriptomic changes and enhancing understanding of bacterial pneumonia dynamics.

The research also included minimum inhibitory concentration (MIC) quantification for different pneumonia pathogens against AMP in varying HS concentrations. This was key in evaluating how HS influences AMP effectiveness against bacterial infections. Rigorous statistical analysis ensured the study's findings were reliable and valid.

Study results 

In the present study, researchers utilized a murine model of MRSA pneumonia. Mass spectrometry analyses revealed a significant increase in HS in the airspace lining fluid of MRSA-infected mice compared to saline controls. Notably, this increase was characterized by a higher abundance of sulfated HS, particularly multi-sulfated disaccharides. Complementary analyses with HME filter samples indicated higher HS levels in patients with gram-negative pneumonia compared to those with gram-positive pneumonia, suggesting a nuanced relationship between bacterial etiology and HS shedding.

Despite the observed increase in shed HS in the lung environment, the study found no direct impact of HS on MRSA growth or gene transcription. Experiments involving various sizes and sulfation patterns of HS showed no significant changes in MRSA growth or transcriptomic response. This finding suggested that HS, while a significant component of the lung milieu post-injury, did not directly inhibit bacterial growth or induce changes in bacterial gene expression.

The study further delved into the interactions between HS and host immune mediators. Using surface plasmon resonance (SPR), the researchers quantified the binding of HS with murine cathelicidin-related antimicrobial peptide (mCRAMP). The strong binding observed indicated a likely interaction in vivo, which could potentially influence the host response to bacterial infection.

Most critically, the study investigated the functional implications of HS binding to mCRAMP. Focusing on common nosocomial pneumonia pathogens including MRSA, Klebsiella pneumoniae, and Pseudomonas aeruginosa, the research employed a modified radial diffusion assay to assess the MIC of mCRAMP against these bacteria.

Results showed significant increases in MIC with higher HS concentrations, indicating a diminished bactericidal effect of mCRAMP in the presence of HS. This finding was particularly noteworthy as it highlighted the complex interplay between HS and host defense mechanisms, where HS, despite not directly affecting MRSA growth, significantly altered the efficacy of an antimicrobial peptide.

Conclusion

Overall, the study underscored the intricate dynamics within the pulmonary environment following bacterial pneumonia. The acute shedding of epithelial HS, particularly when enriched in sulfated forms, presented a nuanced challenge to the host's immune response, potentially influencing the effectiveness of innate immune mechanisms against bacterial pathogens.

Journal reference:
Vijay Kumar Malesu

Written by

Vijay Kumar Malesu

Vijay holds a Ph.D. in Biotechnology and possesses a deep passion for microbiology. His academic journey has allowed him to delve deeper into understanding the intricate world of microorganisms. Through his research and studies, he has gained expertise in various aspects of microbiology, which includes microbial genetics, microbial physiology, and microbial ecology. Vijay has six years of scientific research experience at renowned research institutes such as the Indian Council for Agricultural Research and KIIT University. He has worked on diverse projects in microbiology, biopolymers, and drug delivery. His contributions to these areas have provided him with a comprehensive understanding of the subject matter and the ability to tackle complex research challenges.    

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Kumar Malesu, Vijay. (2024, February 07). Researchers uncover how deadly MRSA pneumonia inhibits body's antimicrobial activity. News-Medical. Retrieved on April 15, 2024 from https://www.news-medical.net/news/20240207/Researchers-uncover-how-deadly-MRSA-pneumonia-inhibits-bodys-antimicrobial-activity.aspx.

  • MLA

    Kumar Malesu, Vijay. "Researchers uncover how deadly MRSA pneumonia inhibits body's antimicrobial activity". News-Medical. 15 April 2024. <https://www.news-medical.net/news/20240207/Researchers-uncover-how-deadly-MRSA-pneumonia-inhibits-bodys-antimicrobial-activity.aspx>.

  • Chicago

    Kumar Malesu, Vijay. "Researchers uncover how deadly MRSA pneumonia inhibits body's antimicrobial activity". News-Medical. https://www.news-medical.net/news/20240207/Researchers-uncover-how-deadly-MRSA-pneumonia-inhibits-bodys-antimicrobial-activity.aspx. (accessed April 15, 2024).

  • Harvard

    Kumar Malesu, Vijay. 2024. Researchers uncover how deadly MRSA pneumonia inhibits body's antimicrobial activity. News-Medical, viewed 15 April 2024, https://www.news-medical.net/news/20240207/Researchers-uncover-how-deadly-MRSA-pneumonia-inhibits-bodys-antimicrobial-activity.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals how SARS-CoV-2 hijacks lung cells to drive COVID-19 severity